FDA Device Intelligence
HomeReshape Lifesciences Inc. › Model 2200A-47E Maestro Anterior Lead

Model 2200A-47E Maestro Anterior Lead

Reshape Lifesciences Inc. · Model 2200A-47E · UDI-DI 00857334004286

PIM Prescription
0
510(k) clearances
67
Adverse events
0
Recalls
3
Facilities

Description

The Model 2200A-47E Anterior Lead is provided sterile for implantation. It is a flexible lead that contains bipolar platinum/iridium tip and ring electrodes with an insulated lead body. Electrical current is delivered to the tip electrode which is implanted to be in contact with the anterior trunk of the vagus nerve to block nerve signals. The ring electrode is placed in contact with the stomach to measure lead impedance. Sutures are used to anchor and stabilize the lead placement. The lead is connected to the implanted Rechargeable Neuroregulator.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.